Acarix AB (publ) Stock Nasdaq Stockholm
Equities
SE0009268717
Advanced Medical Equipment & Technology
Sales 2023 | 6.24M 573K 782K | Sales 2024 * | 86.9M 7.97M 10.88M | Capitalization | 182M 16.72M 22.82M |
---|---|---|---|---|---|
Net income 2023 | -77M -7.07M -9.64M | Net income 2024 * | -24M -2.2M -3.01M | EV / Sales 2023 | 22.4 x |
Net cash position 2023 * | - 0 0 | Net cash position 2024 * | 4 0.37 0.5 | EV / Sales 2024 * | 2.1 x |
P/E ratio 2023 |
-1.19
x | P/E ratio 2024 * |
-
| Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 88.07% |
Latest transcript on Acarix AB (publ)
Managers | Title | Age | Since |
---|---|---|---|
Founder | 60 | 06-12-31 | |
Director of Finance/CFO | 60 | 15-12-31 | |
Jennifer Matson
CTO | Chief Tech/Sci/R&D Officer | 47 | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 51 | 21-05-10 | |
Ulf Rosén
BRD | Director/Board Member | 64 | 13-12-31 |
Director/Board Member | 70 | 21-05-10 |
1st Jan change | Capi. | |
---|---|---|
-12.91% | 19.08B | |
-46.21% | 2.65B | |
+18.15% | 1.87B | |
-3.12% | 1.61B | |
+23.78% | 1.21B | |
-10.69% | 1.02B | |
-20.89% | 905M | |
-7.14% | 716M | |
-18.10% | 682M |